Skip to main content

Measles Races Through Anti-Vax Haven

More than 1,200 people have been infected with the preventable disease in Wales, where health officials are blaming parents who refused the MMR vaccine for their children.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

WIKIMEDIA, US DEPT OF HEALTH AND HUMAN SERVICESIn the late 1990s, many Welsh parents heeded the warnings of former researcher Andrew Wakefield, who published a now-retracted study in 1998 that linked the measles, mumps, and rubella (MMR) vaccine to autism. Fifteen years later, even after the paper was found to be plagued with ethical problems and conflicts of interest, many parents still refuse the vaccine for their children, and a measles outbreak is now racing through Southwest Wales, according to The Wall Street Journal. More than 1,200 people have become infected by the virus that causes measles between November 2012 and this month.

Dai Lloyd is a doctor in Wales who has been treating many of the recent cases. “Despite the fact that it’s one of the greatest health measures ever invented by man or woman, there seems to still be a small residue of humanity that objects to the very idea of immunization,” Lloyd told WSJ. “If you go around the cemetery you can see the historical evidence of childhood slaughter from pre-immunization days.”

England, like the U.S., was poised to declare measles—a highly contagious disease that cause pneumonia, deafness, and, in roughly one out of 1,000 cases, death—“eliminated.” But the U.K. has now reported more than 1,100 cases in 2013 through May, a 64 percent increase from the same months in 2012. “It’s very galling we ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays